Literature DB >> 11520839

Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study.

J Merlo1, H Liedholm, U Lindblad, A Björck-Linné, J Fält, G Lindberg, A Melander.   

Abstract

Mesh：

Year:  2001        PMID： 11520839      PMCID： PMC37552          DOI： 10.1136/bmj.323.7310.427

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Drug Interactions: A Source Book of Adverse Interactions, Their Mechanisms, Clinical Importance and Management.

Authors: 
Journal:  Ann Intern Med       Date:  2000-11-07       Impact factor: 25.391
  1 in total
  32 in total

1.  Safer medicines management in primary care.

Authors:  Anthony J Avery; Aziz Sheikh; Brian Hurwitz; Lesley Smeaton; Yen-Fu Chen; Rachel Howard; Judy Cantrill; Simon Royal
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

2.  Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany.

Authors:  Verena Bergk; Christiane Gasse; Rainer Schnell; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2004-09-04       Impact factor: 2.953

Review 3.  Potential determinants of drug-drug interaction associated dispensing in community pharmacies.

Authors:  Matthijs L Becker; Marjon Kallewaard; Peter W J Caspers; Tom Schalekamp; Bruno H C Stricker
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach.

Authors:  H Ohlsson; U Lindblad; T Lithman; B Ericsson; U-G Gerdtham; A Melander; L Råstam; J Merlo
Journal:  Eur J Clin Pharmacol       Date:  2005-10-19       Impact factor: 2.953

5.  Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies.

Authors:  Tiina Heikkilä; Tuula Lekander; Hannu Raunio
Journal:  Eur J Clin Pharmacol       Date:  2006-06-22       Impact factor: 2.953

6.  Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.

Authors:  Henk Buurma; Peter A G M De Smet; Antoine C G Egberts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 7.  Clinical risk management of herb-drug interactions.

Authors:  Peter A G M De Smet
Journal:  Br J Clin Pharmacol       Date:  2006-11-20       Impact factor: 4.335

8.  Frequency and nature of drug-drug interactions in a Dutch university hospital.

Authors:  Jeannette E F Zwart-van Rijkom; Esther V Uijtendaal; Maarten J ten Berg; Wouter W van Solinge; Antoine C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

9.  Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.

Authors:  Annemieke Floor-Schreudering; Peter A G M De Smet; Henk Buurma; Sonia Amini; Marcel L Bouvy
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

10.  Detection of potential drug interactions - a model for a national pharmacy register.

Authors:  Bengt Astrand; Emelie Astrand; Karolina Antonov; Göran Petersson
Journal:  Eur J Clin Pharmacol       Date:  2006-07-29       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.